444828003: Liraglutide (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Glucagon-like peptide 1 receptor agonist\Liraglutide (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Liraglutide (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Liraglutide (substance)

\Biological substance\Polypeptide\Liraglutide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2010. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2869769011 Liraglutide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2872573011 Liraglutide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

53681000195119 liraglutide it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

820981000172114 liraglutide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

68611000195112 Liraglutid de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Liraglutide (substance)	Is a	Glucagon-like peptide 1 receptor agonist	true	Inferred relationship	Some
Liraglutide (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance product produced by living cells that circulates in body fluids (as blood) or sap and produces a specific effect on the activity of cells usually remote from its point of origin	false	Inferred relationship	Some
Liraglutide (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Glucagon-like peptide 1 receptor agonist	true	Inferred relationship	Some
Liraglutide (substance)	Is a	Polypeptide	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Liraglutide 6mg/mL injection solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Liraglutide (substance)	Inferred relationship	Some
Product containing liraglutide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Liraglutide (substance)	Inferred relationship	Some	1
Product containing insulin degludec and liraglutide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Liraglutide (substance)	Inferred relationship	Some	1
Product containing insulin degludec and liraglutide in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Liraglutide (substance)	Inferred relationship	Some	1
Insulin degludec and liraglutide only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Liraglutide (substance)	Inferred relationship	Some	1
Product containing only liraglutide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Liraglutide (substance)	Inferred relationship	Some	1
Insulin degludec and liraglutide only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Liraglutide (substance)	Inferred relationship	Some	1
Liraglutide-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Liraglutide (substance)	Inferred relationship	Some	1
Product containing only liraglutide in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Liraglutide (substance)	Inferred relationship	Some	1
Liraglutide 6 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Liraglutide (substance)	Inferred relationship	Some	1
Liraglutide 6 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Liraglutide (substance)	Inferred relationship	Some	1
Product containing precisely insulin degludec 100 unit/1 milliliter and liraglutide 3.6 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Liraglutide (substance)	Inferred relationship	Some	1
Product containing precisely insulin degludec 100 unit/1 milliliter and liraglutide 3.6 milligram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Liraglutide (substance)	Inferred relationship	Some	1

This concept is not in any reference sets